Condition

Phase III (2)

Acute Ischemic Stroke (1)

Edaravone Dexborneol (1)

Low-grade Glioma (1)

Mechanical Thrombectomy (1)

Temozolomide (1)

Wait or Treat (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 3 (2)

Sponsor

Beijing Tiantan Hospital (1)

European Organisation for Research and Treatment of Cancer - EORTC (1)

Collaborator

Cooperative Trials Group for Neuro-Oncology (COGNO) (1)

Intervention

edaravone dexborneol concentrated solution for injection (1)

edaravone dexborneol placebo (1)

radiotherapy (1)

surgery (1)

temozolomide (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

phase iii

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Ischemic Stroke, Mechanical Thrombectomy, Edaravone Dexborneol Trial in Beijing (Edaravone Dexborneol Concentrated

Recruiting

Acute Ischemic Stroke
+3 more

Edaravone Dexborneol Concentrated Solution for injection
Edaravone Dexborneol placebo

Beijing, Beijing, China

Beijing Tiantan Hospital, Capital Medical University

Mar 17, 2022

Low-grade Glioma, Temozolomide, Phase III Trial in Worldwide (drug, radiation, procedure)

Terminated

Low-grade Glioma
+3 more

Temozolomide
+2 more

Woolloongabba, Brisbane, QLD, Australia
+44 more

Jan 31, 2022